Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Illumina Names Dr. Robert S. Epstein to its Board of Directors

November 29, 2012 6:30 am | by The Associated Press | News | Comments

SAN DIEGO--(BUSINESS WIRE)--Nov 29, 2012--Illumina, Inc. (NASDAQ: ILMN) today announced that Dr. Robert S. Epstein, M.D., has joined the company’s Board of Directors. Dr. Epstein is an epidemiologist who worked in public health and academia before joining the private sector. Previously, from 2010...

CDRH Export Certification Application and Tracking System (CECATS) Frequently Asked Questions

November 29, 2012 12:00 am | by U.S. Food & Drug Administration | News | Comments

What is CECATS? CECATS is CDRH?s web-based application for accepting requests, reviewing, processing, managing, and administering export certificates, simple notifications, and export permit letters. In the first phase, which begins in November 2012...

Letter to Industry Announcing the Launch of the CDRH Export Certification and Tracking System (CECATS)

November 29, 2012 12:00 am | by U.S. Food & Drug Administration | News | Comments

Today the FDA?s Center for Devices and Radiological Health (CDRH) launched the first phase of a new, Internet-based system for submitting and processing export document requests. The CDRH Export Certification and Tracking System (CECATS) will allow...

Advertisement

Abbott Labs' Worcester facility to become part of spinoff

November 29, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Abbott Laboratories’ (NYSE: ABT) board of directors has voted in favor of a planned spinoff of its pharmaceuticals business, the company said Thursday. As of Jan. 1, 2013, the new drug division, called AbbVie, will begin trading on its own with the ticker symbol (Nasdaq: ABBV).

Spain’s Era7 Bioinformatics opens Cambridge office

November 29, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Era7 Bioinformatics, a Spanish bioinformatics company specializing in bacterial genomics, has opened its first U.S. office, located in the Cambridge Innovation Center (CIC), and expects to hire three employees by the end of 2013.

Obagi Medical Products to Present at The Canaccord Genuity’s Medical Technology and Diagnostics Forum Conference

November 28, 2012 4:33 pm | by The Associated Press | News | Comments

LONG BEACH, Calif.--(BUSINESS WIRE)--Nov 28, 2012--Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced that President and Chief Executive Officer Albert Hummel will present a corporate overview at The Canaccord Genuity’s...

Velomedix Receives IDE Approval for Randomized Pilot Trial to Evaluate Rapid Therapeutic Hypothermia in the Management of Acute Myocardial Infarction Patients

November 28, 2012 3:54 pm | by The Associated Press | News | Comments

MENLO PARK, Calif.--(BUSINESS WIRE)--Nov 28, 2012--Velomedix, Inc., a venture-backed medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to expand the...

Two Leading Researchers to Be Honored at the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium

November 28, 2012 3:52 pm | by AACR | News | Comments

SAN ANTONIO — The 2012 CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers during its 35th annual symposium, which will be held here Dec. 4-8 at the Henry B. Gonzales Convention Center. Kornelia Polyak, M.D., Ph.D., will receive the 2012 AACR Outstanding Investigator Award for Breast Cancer Research, and Mina [...]

Advertisement

Pressure BioSciences Announces Conversion of All Remaining Series E Convertible Preferred Stock by Ironridge BioPharma

November 28, 2012 2:36 pm | by Bio-Medicine.Org | News | Comments

SOUTH EASTON, Mass., Nov. 28, 2012 /- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced that Ironridge BioPharma Co. ("Ironridge") has converted their remaining 200 shares of the Company's Series E Convertible Preferred Stock (the "Series E Preferred Stock") into shares of the Company's common stock.  Following this conversion, all 500 share...

Invisalign trailblazes a path direct to the consumer| A conversation with Align Technology CEO Tom Prescott

November 28, 2012 2:33 pm | by Mass Device | News | Comments

In this MassDevice Big 100 West preview we talk to Align Technology CEO Tom Prescott about how Invisalign crossed the chasm into mainstream culture through social media and aggressive consumer marketing strategies. Crooked-toothed teens may want to consider sliding a picture of Tom Prescott next to that fading "Twilight" poster on the wall.

NEC plans DNA analyzer for nearly-instant results

November 28, 2012 2:16 pm | by I-Micronews | News | Comments

NEC is working on a DNA analyzer that is the size of a suitcase, portable enough to be taken to crime scenes.

New analog front end extends battery life of portable ECG equipment

November 28, 2012 2:00 pm | by Bio-Medicine.Org | News | Comments

DALLAS, Nov. 28, 2012 /- Texas Instruments Incorporated (TI) (NASDAQ: TXN ) expanded its award-winning ADS1298 analog-front-end (AFE) family today with the industry's most power-efficient 24-bit, 3-channel AFE for biopotential measurement applications, such as portable, battery-powered electrocardiogram (ECG) solutions, Holter monitors and wireless patient monitoring equipmen...

St. Jude touts Euro approval for updated CRM implants

November 28, 2012 10:08 am | by Mass Device | News | Comments

Medical device giant St. Jude Medical lands CE Mark approval in the European Union for upgraded versions of its Assura cardiac rhythm management implants. Medical device company St. Jude Medical (NYSE:STJ) announced CE Mark approval in the European Union for its upgraded suite of Assura ICDs...

BF Rated 400 Watt Medical Power Supplies

November 28, 2012 10:06 am | Protek Power | Product Releases | Comments

The PM400 Series’ of AC/DC power supplies from Protek Power offer 400 watts of performance packed design and are approved to 3rd Edition UL60601-1 and EN60601-1 Type BF medical safety standards.

Texas Instruments-based ULP-COM Computer-on-Modules

November 28, 2012 9:59 am | Kontron America Inc. | Product Releases | Comments

Kontron today introduced its latest ULP-COM standards-based Computer-on-Modules to help embedded OEMs drive down system costs for ultra-low power SFF (small form factor) solutions.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading